News related to Revlimid (Lenalidomide) and/or conditions it is approved for
Certain multiple myeloma patients likely to benefit most from panobinostat combination
Source: Clinical Trials / Drug Trials News From Medical News Today [2015.06.22]
A new clinical trial indicates panobinostat combined with bortezomib and dexamethasone shows promise in treating patients with relapsed or relapsed and refractory multiple myeloma.
OWC Pharmaceutical research announces the promising results of phase lab testing for multiple myeloma
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.06.18]
OWC Pharmaceutical Research Corp. have announced that its wholly owned subsidiary, One World Cannabis Ltd.
Navigating multiple myeloma with 'Google Maps' for the cancer genome
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2015.06.09]
In some ways, studying the genetics of cancer has been like examining the individual tiles on a mosaic, says David C.
Source: MedicineNet Multiple Myeloma Specialty [2015.04.30]
Title: Multiple Myeloma
Category: Symptoms and Signs
Created: 4/30/2015 12:00:00 AM
Last Editorial Review: 4/30/2015 12:00:00 AM